MAZE THERAPEUTICS INC (MAZE) Stock Price, Quote, News and Overview

What is the stock price of MAZE THERAPEUTICS INC today?

The current stock price of MAZE is 13.5 USD. The price increased by 1.12% in the last trading session.

What is the ticker symbol for MAZE THERAPEUTICS INC stock?

The exchange symbol of MAZE THERAPEUTICS INC is MAZE and it is listed on the Nasdaq exchange.

On which exchange is MAZE stock listed?

MAZE stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for MAZE THERAPEUTICS INC stock?

12 analysts have analysed MAZE and the average price target is 24.99 USD. This implies a price increase of 85.11% is expected in the next year compared to the current price of 13.5. Check the MAZE THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is MAZE THERAPEUTICS INC worth?

MAZE THERAPEUTICS INC (MAZE) has a market capitalization of 591.30M USD. This makes MAZE a Small Cap stock.

How many employees does MAZE THERAPEUTICS INC have?

MAZE THERAPEUTICS INC (MAZE) currently has 125 employees.

What are the support and resistance levels for MAZE THERAPEUTICS INC (MAZE) stock?

MAZE THERAPEUTICS INC (MAZE) has a support level at 13.47 and a resistance level at 13.75. Check the full technical report for a detailed analysis of MAZE support and resistance levels.

Is MAZE THERAPEUTICS INC (MAZE) expected to grow?

The Revenue of MAZE THERAPEUTICS INC (MAZE) is expected to decline by -98.01% in the next year. Check the estimates tab for more information on the MAZE EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy MAZE THERAPEUTICS INC (MAZE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of MAZE, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of MAZE, evaluating the profitability, health, valuation and growth aspects
• MAZE THERAPEUTICS INC (MAZE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• MAZE THERAPEUTICS INC (MAZE) Sales and EPS estimates to see what analysts future expectations are.
• MAZE THERAPEUTICS INC (MAZE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• MAZE THERAPEUTICS INC (MAZE) Insider and Institutional Ownership to learn about the owners and their transactions.
• MAZE THERAPEUTICS INC (MAZE) Stock Chart to make your own analysis
• MAZE THERAPEUTICS INC (MAZE) Latest news and press-releases to stay up to date.

Does MAZE THERAPEUTICS INC (MAZE) stock pay dividends?

MAZE does not pay a dividend.

What is the Price/Earnings (PE) ratio of MAZE THERAPEUTICS INC (MAZE)?

The PE ratio for MAZE THERAPEUTICS INC (MAZE) is 168.75. This is based on the reported non-GAAP earnings per share of 0.08 and the current share price of 13.5 USD. Check the full fundamental report for a full analysis of the valuation metrics for MAZE.

What is the Short Interest ratio of MAZE THERAPEUTICS INC (MAZE) stock?

The outstanding short interest for MAZE THERAPEUTICS INC (MAZE) is 5.66% of its float. Check the ownership tab for more information on the MAZE short interest.

ChartMill assigns a fundamental rating of 5 / 10 to MAZE. MAZE has an excellent financial health rating, but there are some minor concerns on its profitability.

Over the last trailing twelve months MAZE reported a non-GAAP Earnings per Share(EPS) of 0.08. The EPS increased by 103.39% compared to the year before.

ChartMill assigns a Buy % Consensus number of 87% to MAZE. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of 84.68% and a revenue growth -98.01% for MAZE